Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Dynamac
    Member
    • Aug 2011
    • 46

    #1

    FLX+ Library Amplification Issue

    We are having problems getting our long-fragment shotgun library to amplify during emPCR. Titration using 3 different cpb ratios (12, 18, and 24) yields the same percentage enrichment (3-4%, which doesn't even give us enough beads for a 2-region PTP). A test aqueous phase PCR using Lib-L primers A and B also gives very poor amplification.

    This is a library prepared by restriction enzyme digestion, genome reduction, gel purification and size selection, and finally adaptor ligation. This process has been reported to work in the literature, albeit with the FLX chemistry.

    I'm really perplexed about the non-dependence of cpb on % enrichment. This might be a clue about what's going on. Anyone have any ideas about what is happening?

    I haven't sequenced these beads. I had a look at the ssDNA left in the first melt supernatant on a RNA Nano Chip and saw lots of short fragments and only a smithen of 1000 base product.

    Thanks.

    Barry
  • ajthomas
    Senior Member
    • Mar 2010
    • 167

    #2
    I wouldn't sequence the beads if I were running it. The fact that you saw lots of short fragments indicates that even if there is sequence on those beads the sequence is no good. The information you give (poor performance of the library in liquid-phase PCR coupled with the equal enrichment of all three titrations) suggests that you may have some contamination and the beads you got were mostly from the contaminant rather than the library. There may be other explanations, but that's my first guess.

    Comment

    • Dynamac
      Member
      • Aug 2011
      • 46

      #3
      Thanks, Phillip. I didn't sequence them.

      I don't know how much faith I have in the aqueous PCR result since there isn't a Roche protocol (that I know of) for testing FLX+ shotgun libraries. I was flying by the seat of my pants. I ran a positive control along with it, but that positive control was a Lib-L 16S amplicon, which may not be appropriate. At any rate, I'm going to clean the library again and Roche is going to send me different lots of reagents to try. Could be bad oil.
      Last edited by Dynamac; 12-02-2013, 09:04 AM.

      Comment

      • Dynamac
        Member
        • Aug 2011
        • 46

        #4
        Oops. You aren't Phillip, are you. Sorry about that, I'll just say AJ.

        Comment

        • ajthomas
          Senior Member
          • Mar 2010
          • 167

          #5
          No worries. I've been called worse.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Today, 10:13 AM
          0 responses
          13 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          23 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          19 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          18 views
          0 reactions
          Last Post SEQadmin2  
          Working...